• Sang Jun Song, Young Kook Kim, Min Sung Kim, and Cheol Hee Park.
• Department of Orthopaedic Surgery, Kyung Hee University College of Medicine, Kyung Hee University Medical Center, 26 Kyunghee-daero, Dongdaemun-gu, Seoul, 02447, Korea.
• Arch Orthop Trauma Surg. 2024 Dec 12; 145 (1): 3535.

PurposeTo compare the complication rates between deficient patellae (remnant patellae after component removal) and non-resurfaced patellae after 1.5-stage exchange arthroplasty for periprosthetic joint infection and identify risk factors for complications of deficient patellae.MethodsComplications in 76 deficient patellae (group D) and 41 non-resurfaced patellae (group N), with a minimum follow-up of 2 years after 1.5-stage exchange arthroplasty were retrospectively analyzed. Demographic characteristics and mean follow-up period did not differ between the groups. The incidences of patellar maltracking, erosion, and fractures were investigated. Factors affecting each patellar complication in group D were investigated in terms of age, sex, body mass index, postoperative hip-knee-ankle angle (HKA), remnant patellar thickness, and change in joint line height.ResultsThe incidence of patellar maltracking and erosion was significantly higher in group D than in group N [maltracking: 16 (21.1%) vs. 0 cases (0%), p = 0.001; erosion: 30 (39.5%) vs. 2 cases (4.9%), p < 0.001]. The incidence of patellar fractures tended to be higher in group D [6 (7.8%) vs. 0 cases, p = 0.090]. In group D, postoperative valgus limb alignment and younger age were identified as significant factors that affected patellar maltracking (odds ratio of postoperative HKA = 1.628, p = 0.005) and erosion (odds ratio of age = 0.909, p = 0.009), respectively.ConclusionClose observation of the complications of deficient patellae is required after 1.5-stage exchange arthroplasty. Valgus limb alignment should be avoided to reduce the risk of complications. Early second-stage revision with patellar reconstruction can be considered in younger patients with deficient patellae.Level Of EvidenceIII.© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

28 keywords...

hide…